Literature DB >> 11297938

Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy.

S Fletcher1, T Ly, R M Duff, J McC Howell, S D Wilton.   

Abstract

Golden retriever muscular dystrophy arises from a mutation in the acceptor splice site of intron 6 of the dystrophin gene. Skipping of exon 7 disrupts the mRNA reading frame and results in premature termination of translation. We are using this animal model to evaluate treatments for Duchenne muscular dystrophy, including gene repair induced by chimeric oligonucleotides. After injection of golden retriever muscular dystrophy (GRMD) muscle with a chimeric oligonucleotide to repair the lesion, immunostaining revealed a modest increase in the number of dystrophin-positive fibres at the injection sites. Dystrophin gene transcripts containing exon 7 were detected by reverse transcription-polymerase chain reaction, suggesting that low levels of splice site correction may have occurred. However, DNA sequencing of these apparently normal dystrophin gene transcripts revealed that the first five bases of exon 7 were missing. It will be important to be aware of this phenomenon with respect to further gene correction studies in the canine model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297938     DOI: 10.1016/s0960-8966(00)00187-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Authors:  Karl Rouger; Thibaut Larcher; Laurence Dubreil; Jack-Yves Deschamps; Caroline Le Guiner; Gregory Jouvion; Bruno Delorme; Blandine Lieubeau; Marine Carlus; Benoît Fornasari; Marine Theret; Priscilla Orlando; Mireille Ledevin; Céline Zuber; Isabelle Leroux; Stéphane Deleau; Lydie Guigand; Isabelle Testault; Elisabeth Le Rumeur; Marc Fiszman; Yan Chérel
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

Review 2.  Duchenne muscular dystrophy gene therapy in the canine model.

Authors:  Dongsheng Duan
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-24       Impact factor: 5.032

3.  Kinematics of gait in golden retriever muscular dystrophy.

Authors:  Anthony P Marsh; Joel D Eggebeen; Joe N Kornegay; Chad D Markert; Martin K Childers
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

4.  MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.

Authors:  I M Barbash; S Cecchini; A Z Faranesh; T Virag; L Li; Y Yang; R F Hoyt; J N Kornegay; J R Bogan; L Garcia; R J Lederman; R M Kotin
Journal:  Gene Ther       Date:  2012-05-03       Impact factor: 5.250

5.  Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.

Authors:  May T Aung-Htut; Craig S McIntosh; Kristin A Ham; Ianthe L Pitout; Loren L Flynn; Kane Greer; Sue Fletcher; Steve D Wilton
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

6.  Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.

Authors:  Maura H Parker; Christian Kuhr; Stephen J Tapscott; Rainer Storb
Journal:  Mol Ther       Date:  2008-05-27       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.